SCHEMBL7940342

SCHEMBL7940342

CC(C)C[C@@H](C(=O)NN(c1ccccc1)S(=O)(=O)Cc1ccccc1)[C@H](CC=Cc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 4/20 0.52
PSMB5 P28074 3/20 0.35
REN P00797 3/20 0.34
MMP2 P08253 7/20 0.33
MMP3 P08254 6/20 0.33
MMP7 P09237 5/20 0.33
MMP1 P03956 7/20 0.33
MMP8 P22894 3/20 0.33
MMP9 P14780 2/20 0.33
MMP13 P45452 2/20 0.33
MAPT P10636 2/20 0.33
ATM Q13315 2/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
MMP12 P39900 1/20 0.33
MMP14 P50281 1/20 0.33
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6940910 0.88 ADAM17 (0.67) ADAM17MMP2MMP3MMP7MMP1
SCHEMBL7935009 0.82 ADAM17 (0.76) ADAM17PSMB5RENMMP1MMP9
SCHEMBL6941589 0.82 ADAM17 (0.49) ADAM17PSMB5MMP2MMP3MMP7
SCHEMBL6945362 0.81 ADAM17 (0.54) ADAM17PSMB5MMP1MMP9MMP13
SCHEMBL6939553 0.80 ADAM17 (0.51) ADAM17PSMB5MMP2MMP3MMP7
SCHEMBL6948147 0.79 ADAM17 (0.55) ADAM17ALDH1A1
SCHEMBL6948137 0.79 ADAM17 (0.55) ADAM17ALDH1A1
SCHEMBL6945274 0.79 ADAM17 (0.47) ADAM17MMP2MMP3MMP7MMP1
SCHEMBL6220502 0.79 ADAM17 (0.48) ADAM17RENMAPTATMALDH1A1
SCHEMBL6220496 0.79 ADAM17 (0.48) ADAM17RENMAPTATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed